NASDAQ : CNTB

Connect Biopharma Holdings Limited — Financial statements

Healthcare · Biotechnology · United States

Last price 0.8022 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 50.52M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Connect Biopharma Holdings Limited (CNTB) reported revenue of 2.95M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue2.95M64.00K26.03M
Gross Profit2.95M64.00K26.03M
Selling, General & Admin19.67M20.34M17.43M16.05M20.81M19.01M
Research & Development53.70M37.80M27.86M53.00M96.63M80.50M
Other Operating Expenses-1.08M-1.85M
Operating Expenses73.37M58.14M45.28M69.06M116.36M97.66M
Operating Income-70.41M-58.07M-19.25M-69.06M-116.36M-97.66M
Interest Expense-21.00K-7.00K
Interest & Investment Income1.50M2.27M4.45M5.22M1.81M165.00K
Currency Exchange Gain (Loss)1.47M-516.00K
Other Non Operating Income (Expenses)117.00K523.00K2.59M1.85M-103.98M
EBT Excluding Unusual Items-68.80M-55.28M-12.21M-61.99M-113.09M-202.00M
Asset Writedown-4.70M
Other Unusual Items-3.20M
Pretax Income-68.80M-55.28M-15.40M-61.99M-117.79M-202.00M
Income Tax Expense196.00K197.00K223.00K120.00K298.00K266.00K
Earnings From Continuing Operations-68.99M-55.48M-15.63M-62.11M-118.09M-202.27M
Net Income-68.99M-55.48M-15.63M-62.11M-118.09M-202.27M
Net Income to Common-68.99M-55.48M-15.63M-62.11M-118.09M-202.27M
Shares Outstanding (Basic)57.81M55.66M55.21M55.07M55.04M52.18M
Shares Outstanding (Diluted)57.81M55.66M55.21M55.07M55.04M52.18M
EPS (Basic)-1.19-1.00-0.28-1.13-2.15-3.88
EPS (Diluted)-1.19-1.00-0.28-1.13-2.15-3.88
Free Cash Flow-60.63M-51.64M-24.36M-47.82M-105.92M-88.16M
Free Cash Flow Per Share-1.05-0.93-0.44-0.87-1.92-1.69
Gross Margin100.00%100.00%100.00%
Operating Margin-2,384.49%-90,740.62%-73.95%
Profit Margin-2,336.30%-86,687.50%-60.03%
Free Cash Flow Margin-2,053.27%-80,687.50%-93.58%
EBITDA-69.73M-57.37M-18.59M-68.34M-115.62M-97.17M
EBITDA Margin-71.42%
D&A For EBITDA685.00K704.00K660.00K720.00K732.00K493.00K
EBIT-70.41M-58.07M-19.25M-69.06M-116.36M-97.66M
EBIT Margin-73.95%

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents27.02M38.34M78.23M105.66M79.01M267.72M
Short-Term Investments4.47M6.00M15.48M12.64M73.46M
Cash & Short-Term Investments31.49M44.34M93.71M118.30M152.47M267.72M
Accounts Receivable2.94M13.00K789.00K
Other Receivables22.00K148.00K262.00K351.00K7.41M
Receivables2.96M161.00K1.05M351.00K7.41M
Prepaid Expenses4.18M6.43M2.20M3.85M3.31M
Other Current Assets54.00K
Total Current Assets38.62M50.93M96.96M122.55M155.78M275.13M
Property, Plant & Equipment4.16M4.46M4.24M4.74M8.47M12.89M
Long-Term Investments9.44M
Other Intangible Assets42.00K45.00K53.00K62.00K72.00K88.00K
Other Long-Term Assets646.00K646.00K33.00K24.00K252.00K2.95M
Total Assets43.47M56.08M101.28M127.38M174.01M291.05M
Accounts Payable2.02M1.96M342.00K2.21M11.94M12.73M
Accrued Expenses13.89M11.16M7.80M9.48M2.96M
Current Portion of Leases393.00K322.00K154.00K285.00K186.00K99.00K
Current Unearned Revenue167.00K164.00K13.32M
Other Current Liabilities537.00K5.15M
Total Current Liabilities16.30M13.61M8.46M25.29M15.62M17.98M
Long-Term Leases203.00K368.00K24.00K180.00K245.00K26.00K
Long-Term Unearned Revenue652.00K784.00K
Other Long-Term Liabilities107.00K114.00K632.00K405.00K
Total Liabilities16.61M14.10M9.12M25.88M16.52M18.80M
Common Stock11.00K10.00K10.00K10.00K10.00K10.00K
Additional Paid-In Capital465.51M444.18M439.36M432.40M628.66M628.64M
Retained Earnings-437.52M-400.83M-345.36M-329.73M-479.84M-361.75M
Treasury Stock-180.00K-180.00K-180.00K-180.00K-180.00K-180.00K
Comprehensive Income & Other-962.00K-1.19M-1.67M-1.01M8.85M5.54M
Shareholders' Equity26.86M41.98M92.17M101.50M157.49M272.26M
Total Liabilities & Equity43.47M56.08M101.28M127.38M174.01M291.05M
Total Debt596.00K690.00K178.00K465.00K431.00K125.00K
Net Cash (Debt)30.89M43.65M93.53M117.84M152.04M267.59M
Net Cash Per Share0.530.781.692.142.765.13
Filing Date Shares Outstanding62.97M56.52M55.35M55.10M55.04M55.08M
Total Common Shares Outstanding62.97M56.44M55.35M55.10M55.04M55.08M
Working Capital22.32M37.32M88.50M97.26M140.16M257.14M
Book Value Per Share0.430.741.671.842.864.94
Tangible Book Value26.82M41.94M92.11M101.44M157.42M272.17M
Tangible Book Value Per Share0.430.741.661.842.864.94
Machinery6.24M5.85M5.68M5.83M5.77M
Construction In Progress3.70M
Leasehold Improvements859.00K830.00K626.00K762.00K733.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-68.99M-55.48M-15.63M-62.11M-118.09M-202.27M
Depreciation & Amortization685.00K704.00K660.00K720.00K1.03M634.00K
Loss (Gain) From Sale of Assets3.00K37.00K9.00K102.00K39.00K
Asset Writedown & Restructuring Costs232.00K4.70M
Loss (Gain) From Sale of Investments-246.00K-773.00K-123.00K-1.70M
Stock-Based Compensation4.29M3.73M6.73M5.40M6.91M8.99M
Other Operating Activities-2.52M104.70M
Change in Accounts Receivable-2.94M776.00K-789.00K4.05M-2.31M
Change in Accounts Payable-278.00K1.62M-1.87M-1.14M-776.00K8.97M
Change in Unearned Revenue-164.00K3.00K-13.16M13.32M
Change in Other Net Operating Assets7.05M-1.82M322.00K-2.33M3.19M-3.08M
Operating Cash Flow-60.58M-51.21M-23.61M-47.74M-101.52M-84.32M
Capital Expenditures-50.00K-434.00K-750.00K-81.00K-4.41M-3.83M
Sale of Property, Plant & Equipment2.00K2.00K
Sale (Purchase) of Intangibles2.94M-48.00K
Investment in Securities26.91M10.25M-2.70M72.12M-81.84M2.12M
Other Investing Activities-3.44M
Investing Cash Flow26.86M9.82M-3.45M74.98M-86.24M-5.21M
Long-Term Debt Repaid-222.00K-126.00K
Lease Payments-222.00K-126.00K
Net Debt Issued (Repaid)-222.00K-126.00K
Issuance of Common Stock21.40M1.09M227.00K45.00K137.00K220.02M
Repurchase of Common Stock-566.00K
Other Financing Activities-1.52M-17.11M
Financing Cash Flow19.88M1.09M227.00K45.00K-85.00K202.22M
Foreign Exchange Rate Adjustments226.00K408.00K-595.00K-568.00K-858.00K224.00K
Net Cash Flow-13.62M-39.89M-27.43M26.72M-188.71M112.91M
Free Cash Flow-60.63M-51.64M-24.36M-47.82M-105.92M-88.16M
Free Cash Flow Margin-2,053.27%-80,687.50%-93.58%
Free Cash Flow Per Share-1.05-0.93-0.44-0.87-1.92-1.69
Levered Free Cash Flow-34.71M-30.65M-21.10M-25.55M-67.55M-46.03M
Unlevered Free Cash Flow-34.71M-30.65M-21.10M-25.55M-67.54M-46.02M
Free Cash Flow After Leases-60.63M-51.64M-24.36M-47.82M-106.15M-88.28M
Cash Income Tax Paid179.00K292.00K111.00K120.00K
Change in Working Capital3.67M580.00K-15.49M9.85M6.46M3.58M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization50.52M157.65M
Enterprise Value19.63M103.65M
Last Close Price0.802.82
PS Ratio17.112,463.25
PB Ratio1.883.75
P/TBV Ratio1.883.76
EV/Sales Ratio6.651,619.50
Debt / Equity Ratio0.020.020.000.010.000.00
Net Debt / Equity Ratio-1.15-1.04-1.01-1.16-0.96-0.98
Net Debt / EBITDA Ratio0.440.765.031.721.312.75
Net Debt / FCF Ratio0.510.843.842.461.443.04
Asset Turnover0.050.000.23
Quick Ratio2.113.2711.204.699.7615.30
Current Ratio2.373.7411.464.849.9715.30
Return on Equity (ROE)-140.51%-82.72%-16.14%-47.96%-54.96%-364.72%
Return on Assets (ROA)-69.75%-46.13%-10.52%-28.64%-31.27%-26.43%
Return on Capital Employed (ROCE)-259.20%-136.80%-20.70%-67.60%-73.50%-35.80%
Earnings Yield-148.76%-35.19%
FCF Yield-120.02%-32.76%
Buyback Yield / Dilution-4.44%-0.81%-0.27%-0.04%-5.50%-205.31%